CFDE Data Portal | Search RAB17

	Label	Description
	RAB17 Gene (Entity type)	ENSG00000124839 - RAB17, member RAS oncogene family
	RAB17 associations Collection (Entity type)	Associations for RAB17_associations
	RAB17 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	RAB17-DT Gene (Entity type)	ENSG00000234949 - RAB17 divergent transcript
	KFGENEBIN:RAB17-variant-count CUI gene has variants RAB17 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Kids First
	GSE110178 2 V 3 TRANYLCYPROMINE MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE229973 3 V 2 CISPLATIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE102467 3 V 2 PAZOPANIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE255432 7 V 3 IMEGLIMIN MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE134191 3 V 1 METFORMIN MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS

RAB17

ENSG00000124839 - RAB17, member RAS oncogene family

RAB17 associations

Associations for RAB17_associations

RAB17 associations.tsv

A file from IDG as part of the Harmonizome project

RAB17-DT

ENSG00000234949 - RAB17 divergent transcript

KFGENEBIN:RAB17-variant-count CUI gene has variants RAB17

A Knowledge Graph Assertion from Kids First

GSE110178 2 V 3 TRANYLCYPROMINE MOUSE DN

A Gene Set from LINCS

GSE229973 3 V 2 CISPLATIN HUMAN DN

A Gene Set from LINCS

GSE102467 3 V 2 PAZOPANIB HUMAN UP

A Gene Set from LINCS

GSE255432 7 V 3 IMEGLIMIN MOUSE UP

A Gene Set from LINCS

GSE134191 3 V 1 METFORMIN MOUSE DN

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.